Hirtle Callaghan & Co’s Xylem XYL Stock Holding History

Hirtle Callaghan & Co’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-3,051	Closed	-$116K	–	377
2014 Q4	$116K	Hold	3,051	–	–	0.03%	225
2014 Q3	$108K	Hold	3,051	–	–	0.02%	234
2014 Q2	$119K	Hold	3,051	–	–	0.02%	276
2014 Q1	$111K	Hold	3,051	–	–	0.02%	278
2013 Q4	$106K	Hold	3,051	–	–	0.01%	268
2013 Q3	$85K	Buy	+3,051	New	+$81.3K	0.01%	292

Other funds holding XYL

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Hirtle Callaghan & Co's XYL Position: Q1 2015 in Review

Hirtle Callaghan & Co sold out of Xylem (XYL) in Q1 2015, closing a stake of 3,051 shares — an estimated $116K sold.

Hirtle Callaghan & Co first reported a position in XYL in Q3 2013 and held it in 6 quarters. The position peaked at $119K in Q2 2014. 429 funds tracked by Wall St. Rank hold XYL as of Q1 2015.

Hirtle Callaghan & Co reported no remaining Xylem position as of Q1 2015 after selling out during the quarter.
Hirtle Callaghan & Co sold 3,051 Xylem shares in Q1 2015, an estimated $116K.
Hirtle Callaghan & Co first reported a position in Xylem in Q3 2013 and held it in 6 quarters.
Hirtle Callaghan & Co's Xylem position peaked at $119K in Q2 2014.
429 funds tracked by Wall St. Rank held Xylem as of Q1 2015.

Based on Hirtle Callaghan & Co's 13F filing for Q1 2015, filed 15 May 2015.